Multi-Industry Occlusion Balloon Catheter Applications

Publication ID: 24-11857737_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Multi-Industry Occlusion Balloon Catheter Applications,” Published Technical Disclosure No. 24-11857737_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857737_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,737.

Summary of the Inventive Concept

This inventive concept extends the core technology of the original low-profile occlusion balloon catheter to address diverse industry challenges, including water contamination, soil moisture monitoring, aircraft fuel line ice prevention, industrial process fluid contamination, and chemical plant fluid flow control.

Background and Problem Solved

The original patent's occlusion balloon catheter system was designed for vascular pre-conditioning and occlusion procedures. However, its limitations in terms of adaptability to other industries and applications hindered its broader impact. This new inventive concept overcomes these limitations by applying the core technology to entirely different industries and fields, solving specific problems in each domain.

Detailed Description of the Inventive Concept

The new inventive concept comprises a family of occlusion balloon catheter systems tailored to address unique challenges in various industries. For instance, the system for treating water contamination uses the occlusion balloon catheter to block contaminated water flow and allow for controlled water treatment. Similarly, the system for monitoring and controlling soil moisture levels employs the occlusion balloon catheter to measure and regulate water absorption rates. In the aerospace industry, the device prevents ice formation in aircraft fuel lines by blocking ice formation and allowing for controlled fuel flow. In industrial process fluid contamination, the method uses the occlusion balloon catheter to block contaminated fluid flow and allow for controlled fluid treatment. Lastly, the system for monitoring and controlling fluid flow in a chemical plant measures and regulates fluid flow rates using the occlusion balloon catheter.

Novelty and Inventive Step

The new claims introduce novel applications and use cases for the occlusion balloon catheter technology, expanding its scope beyond vascular procedures. The inventive step lies in recognizing the adaptability of the core technology to diverse industries and developing specific implementations that address unique challenges in each domain.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include modifications to the occlusion balloon catheter's material, size, and shape to accommodate specific industry requirements. Variations could also involve integrating sensors, actuators, or other components to enhance the system's functionality and precision.

Potential Commercial Applications and Market

The multi-industry occlusion balloon catheter applications have significant commercial potential, targeting industries such as water treatment, agriculture, aerospace, industrial process control, and chemical processing. The market potential is substantial, with opportunities for partnerships, licensing, and product development.

CPC Classifications

SectionClassGroup
A A61 A61M25/0068
A A61 A61B17/12036
A A61 A61M25/008
A A61 A61M25/0074
A A61 A61M25/1002
A A61 A61M25/104
A A61 A61M25/1006
A A61 A61M25/10182
A A61 A61B17/12045
A A61 A61B17/12109
A A61 A61B2017/00017
A A61 A61M25/007
A A61 A61M2025/0002
A A61 A61M2025/1052
A A61 A61M2025/1059
A A61 A61M2025/1081
A A61 A61M2025/1084
A A61 A61M2025/1086
A A61 A61M2025/1093

Original Patent Information

Patent NumberUS 11,857,737
TitleSystem and method for low-profile occlusion balloon catheter
Assignee(s)PRYTIME MEDICAL DEVICES, INC.